19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1156 26 1357 94 1144 171 1041
ERLYTX 86 1 52 6 73 18 110
GI 169 1 52 13 158 28 170
GU 342 6 313 36 438 73 444
LEUK 160 2 104 13 158 36 219
LUNG 209 8 417 22 268 43 262
LYMPH 417 5 261 33 402 75 457
MELAN 55 0 0 0 0 0 0
MMYEL 116 2 104 7 85 22 134
MULT 48 1 52 4 49 10 61
OTHER 54 0 0 4 49 7 43
SXQOL 4 1 52 2 24 4 24
Total 2816 53 2764 234 2848 487 2965

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  3 2 104 3 37 3 18
CCD 181 4 209 25 304 41 250
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 0 0
LEUK 617 12 626 46 560 98 597
LUNG 378 7 365 29 353 55 335
OTHER 12 0 0 1 12 1 6
PEOLC 93 0 0 3 37 5 30
PREV 251 2 104 14 170 43 262
SXQOL 640 20 1044 45 548 92 560
Total 2184 47 2452 167 2033 339 2064

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  3 2 104 3 37 3 18
BREAST 1156 26 1357 94 1144 171 1041
CCD 181 4 209 25 304 41 250
ERLYTX 91 1 52 7 85 19 116
GI 169 1 52 13 158 28 170
GU 346 6 313 36 438 73 444
LEUK 777 14 730 59 718 134 816
LUNG 587 15 783 51 621 98 597
LYMPH 417 5 261 33 402 75 457
MELAN 55 0 0 0 0 0 0
MMYEL 116 2 104 7 85 22 134
MULT 48 1 52 4 49 10 61
OTHER 66 0 0 5 61 8 49
PEOLC 93 0 0 3 37 5 30
PREV 251 2 104 14 170 43 262
SXQOL 644 21 1096 47 572 96 584
Total 5000 100 5217 401 4881 826 5029

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 716 17 887 58 706 99 603
ERLYTX 55 1 52 5 61 13 79
GI 126 1 52 11 134 20 122
GU 260 4 209 23 280 52 317
LEUK 99 1 52 8 97 22 134
LUNG 128 6 313 12 146 26 158
LYMPH 275 4 209 20 244 51 310
MELAN 36 0 0 0 0 0 0
MMYEL 66 1 52 4 49 10 61
MULT 19 1 52 3 37 5 30
OTHER 54 0 0 4 49 7 43
SXQOL 4 1 52 2 24 4 24
Total 1838 37 1930 150 1827 309 1881

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  3 2 104 3 37 3 18
CCD 139 3 157 17 207 28 170
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 0 0
LEUK 264 3 157 16 195 44 268
LUNG 227 3 157 17 207 31 189
OTHER 12 0 0 1 12 1 6
PEOLC 72 0 0 3 37 5 30
PREV 251 2 104 14 170 43 262
SXQOL 467 15 783 33 402 63 384
Total 1444 28 1462 105 1279 219 1333

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  5 4 209 5 61 5 30
BREAST 892 22 1148 73 889 128 779
CCD 164 3 157 14 170 24 146
ERLYTX 60 1 52 6 73 14 85
GI 130 1 52 12 146 21 128
GU 295 4 209 27 329 55 335
LEUK 364 4 209 24 292 66 402
LUNG 377 8 417 32 390 59 359
LYMPH 275 4 209 20 244 51 310
MELAN 36 0 0 0 0 0 0
MMYEL 66 1 52 4 49 10 61
MULT 40 0 0 1 12 4 24
OTHER 163 0 0 5 61 8 49
PEOLC 73 0 0 4 49 9 55
PREV 251 2 104 14 170 43 262
SXQOL 471 16 835 35 426 67 408
Total 3662 70 3653 276 3361 564 3433

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 980 26 1357 87 1059 158 962
ERLYTX 81 1 52 6 73 18 110
GI 101 0 0 8 97 18 110
GU 241 3 157 25 304 54 329
LEUK 128 2 104 12 146 32 195
LUNG 183 7 365 20 244 40 244
LYMPH 350 4 209 27 329 64 390
MMYEL 102 1 52 6 73 20 122
MULT 48 1 52 4 49 10 61
Total 2214 45 2348 195 2374 414 2523

19-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1923 27 1409 132 1607 296 1802
AFFIL 140 2 104 6 73 21 128
CCOP/NCORP 1219 36 1878 117 1424 211 1284
Non-SWOG 1717 34 1774 145 1765 297 1808
Total 4999 99 5165 400 4869 825 5022

19-JUL-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26

19-JUL-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 1 E 30-JUN-26
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 2 E 30-JUN-26
OTHER NRGBN013 Brain, Intact Metas, SRS vs FSRS 1 E 22-JUN-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26

19-JUL-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 23
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 14
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 12
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 7
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 2 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 3
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3